Clovis Oncology Announces 2014 Objectives And Financial Guidance
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced anticipated development milestones and financial guidance for 2014. Clovis currently has three clinical development programs underway, and expects to initiate four registration studies for two of its programs during the first half of 2014.
Help employers find you! Check out all the jobs and post your resume.